Pakistan · Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 4.93 billion. The enterprise value is 4.88 billion.
| Market Cap | 4.93B |
| Enterprise Value | 4.88B |
Important Dates
The last earnings date was Friday, October 3, 2025.
| Earnings Date | Oct 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 98.53 million shares outstanding.
| Current Share Class | 98.53M |
| Shares Outstanding | 98.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 4.41% |
| Float | 24.81M |
Valuation Ratios
The trailing PE ratio is 23.64.
| PE Ratio | 23.64 |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.79, with an EV/FCF ratio of -17.49.
| EV / Earnings | 23.40 |
| EV / Sales | 1.13 |
| EV / EBITDA | 10.79 |
| EV / EBIT | 10.97 |
| EV / FCF | -17.49 |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.02 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | -0.57 |
| Interest Coverage | 7.63 |
Financial Efficiency
Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 12.03%.
| Return on Equity (ROE) | 9.39% |
| Return on Assets (ROA) | 7.57% |
| Return on Invested Capital (ROIC) | 12.03% |
| Return on Capital Employed (ROCE) | 18.98% |
| Revenue Per Employee | 19.30M |
| Profits Per Employee | 930,228 |
| Employee Count | 224 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, IBL HealthCare has paid 168.72 million in taxes.
| Income Tax | 168.72M |
| Effective Tax Rate | 44.74% |
Stock Price Statistics
The stock price has increased by +106.47% in the last 52 weeks. The beta is 0.72, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +106.47% |
| 50-Day Moving Average | 52.24 |
| 200-Day Moving Average | 43.35 |
| Relative Strength Index (RSI) | 48.71 |
| Average Volume (20 Days) | 543,986 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.32 billion and earned 208.37 million in profits. Earnings per share was 2.11.
| Revenue | 4.32B |
| Gross Profit | 1.44B |
| Operating Income | 444.59M |
| Pretax Income | 377.09M |
| Net Income | 208.37M |
| EBITDA | 447.81M |
| EBIT | 444.59M |
| Earnings Per Share (EPS) | 2.11 |
Balance Sheet
The company has 208.94 million in cash and 158.98 million in debt, giving a net cash position of 49.96 million or 0.51 per share.
| Cash & Cash Equivalents | 208.94M |
| Total Debt | 158.98M |
| Net Cash | 49.96M |
| Net Cash Per Share | 0.51 |
| Equity (Book Value) | 2.32B |
| Book Value Per Share | 23.58 |
| Working Capital | 1.70B |
Cash Flow
In the last 12 months, operating cash flow was -259.67 million and capital expenditures -19.15 million, giving a free cash flow of -278.81 million.
| Operating Cash Flow | -259.67M |
| Capital Expenditures | -19.15M |
| Free Cash Flow | -278.81M |
| FCF Per Share | -2.83 |
Margins
Gross margin is 33.40%, with operating and profit margins of 10.29% and 4.82%.
| Gross Margin | 33.40% |
| Operating Margin | 10.29% |
| Pretax Margin | 8.72% |
| Profit Margin | 4.82% |
| EBITDA Margin | 10.36% |
| EBIT Margin | 10.29% |
| FCF Margin | n/a |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.08% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.23% |
| FCF Yield | -5.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 7, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Oct 7, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
IBL HealthCare has an Altman Z-Score of 3.57 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.57 |
| Piotroski F-Score | 4 |